Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Auvelity ema submission or application status 2024 or 2025?Semaglutide patent status expiration china generics?Metformin hydrochloride prolonged release tablets?Janumet manufacturer?Amoxicillin brands in pakistan?
See the DrugPatentWatch profile for Skyrizi
Skyrizi’s generic (active ingredient) name is risankizumab. [1]
Skyrizi is a biologic monoclonal antibody (risankizumab), not a traditional small-molecule drug, so any later “generic” versions are typically biosimilars rather than identical chemical generics. [1]
Skyrizi (risankizumab) is tracked on DrugPatentWatch.com, which maintains patent and exclusivity information for the product. [1]
[1] https://www.drugpatentwatch.com/p/risankizumab-skyrizi
Other Questions About Skyrizi :